0001493152-20-009960.txt : 20200527 0001493152-20-009960.hdr.sgml : 20200527 20200527180543 ACCESSION NUMBER: 0001493152-20-009960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200522 FILED AS OF DATE: 20200527 DATE AS OF CHANGE: 20200527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sinha Shishir K. CENTRAL INDEX KEY: 0001812640 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 20916468 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: SUITE B CITY: CARLSBAD STATE: CA ZIP: 92011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 310-203-1000 MAIL ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 FORMER COMPANY: FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090402 4 1 ownership.xml X0306 4 2020-05-22 0 0001460702 Qualigen Therapeutics, Inc. QLGN 0001812640 Sinha Shishir K. C/O QUALIGEN THERAPEUTICS, INC., 2042 CORTE DEL NOGAL CARLSBAD CA 92011 0 1 0 0 Vice President of Operations Warrant (Right to Buy) 2.0663 2020-05-22 4 J 0 8857 A 2020-05-22 2024-01-31 Common Stock 8857 8857 D Warrant (Right to Buy) 2.0663 2020-05-22 4 J 0 26570 A 2020-05-22 2024-08-20 Common Stock 26570 26570 D On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became an officer of the Issuer. Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. /s/ Hayden Trubitt, Attorney-in-Fact for Shishir K. Sinha 2020-05-27